Cargando…
Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts
Creatine transporter deficiency (CTD) is a metabolic disorder resulting in cognitive, motor, and behavioral deficits. Cyclocreatine (cCr), a creatine analog, has been explored as a therapeutic strategy for the treatment of CTD. We developed a rapid, selective, and accurate HILIC ultra‐performance li...
Autores principales: | Gorshkov, Kirill, Wang, Amy Q., Sun, Wei, Fisher, Ethan, Frigeni, Marta, Singleton, Marc, Thorne, Natasha, Class, Bradley, Huang, Wenwei, Longo, Nicola, Do, Minh‐Ha T., Ottinger, Elizabeth A., Xu, Xin, Zheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924099/ https://www.ncbi.nlm.nih.gov/pubmed/31859463 http://dx.doi.org/10.1002/prp2.525 |
Ejemplares similares
-
Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression
por: Patel, Rachana, et al.
Publicado: (2022) -
The pharmacology and therapeutic applications of monoclonal antibodies
por: Castelli, María Sofía, et al.
Publicado: (2019) -
Therapeutic utility of glucocorticoids and antihistamines cotreatment. Rationale and perspectives
por: Zappia, Carlos D., et al.
Publicado: (2019) -
MicroRNAs in non‐small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential
por: Petrek, Hannah, et al.
Publicado: (2019) -
Stepping Up: How U.S. Neurosurgery Training Programs Can Innovatively Assess Resident Applicants in a Post-Step 1 World
por: Bhandarkar, Archis R., et al.
Publicado: (2020)